A clinical trial update involving GHK-Cu was recorded on October 22, 2026. The study, titled "Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks," is registered under identifier NCT07888595. It is listed as an early phase 1 trial. Its current status is enrolling by invitation, meaning participants are being recruited through direct invitation rather than open enrollment. The trial description indicates it will assess systemic and topical geroprotective approaches using START and REST aging clock measurements, as named in the registered title. No results have been posted for this trial at this time. No efficacy, safety outcomes, or findings should be inferred from this update, since only the trial's registration details and status are available. Readers interested in the development of GHK-Cu as an investigational approach can monitor this trial's progress through its clinical trial registry listing. For additional context on GHK-Cu, including its current regulatory status and background, readers can consult the compound overview.
GHK-Cu Featured in Early Phase 1 Trial on Aging Clocks
Source: https://clinicaltrials.gov/study/NCT07888595